Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cancer Vaccines: Drug Pipeline Update 2008 Out Now.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c35509) has announced the addition of "Cancer Vaccines Cancer vaccines
A treatment that uses the patient's immune system to attack cancer cells.

Mentioned in: Pancreatic Cancer, Exocrine
: Drug Pipeline Update 2008" to their offering.

The development of cancer vaccines has been a real roller-coaster, from the early excitement to the total disillusionment Disillusionment
Adams, Nick

loses innocence through WWI experience. [Am. Lit.: “The Killers”]

Angry Young Men

disillusioned postwar writers of Britain, such as Osborne and Amis. [Br. Lit.
 and now to the resurrection. Today, there are more than 170 companies developing more than 260 non-antibody based vaccine drugs, therapeutic and preventive vaccines included. Vaccines are being developed for over 30 different cancer indications and the number of vaccine targets has increased to over 50 different molecular targets in just a few years.

Non-Antibody Based Cancer Vaccines: Drug Pipeline Update provides extensive research and development information with global coverage, vital for any serious player in the field.

Read more below how Non-Antibody Based Cancer Vaccines: Drug Pipeline Update is organized:

Investigators Includes more than 170 investigators

Drug name & Synonyms Lists commercial, generic and code names for drugs. In all more than 400 names

Developmental stage Contains more than 260 non-antibody vaccine drugs in development or more than 350 clinical projects for cancer:

greater than 18 projects in Phase III

greater than 85 projects in Phase II

greater than 115 projects in Phase I

greater than 125 projects in Preclinical

Cancer Indications PKI (Public Key Infrastructure) A framework for creating a secure method for exchanging information based on public key cryptography. The foundation of a PKI is the certificate authority (CA), which issues digital certificates that authenticate the identity of  drugs in development for over 30 cancer indications

- Breast cancer

- Colorectal cancer colorectal cancer

Malignant tumour of the large intestine (colon) or rectum. Risk factors include age (after age 50), family history of colorectal cancer, chronic inflammatory bowel diseases, benign polyps, physical inactivity, and a diet high in fat.
 

- Hematological hematological, hematologic

pertaining to or emanating from blood cells.


hematological tests
total and differential white cell counts, hematocrit estimation, erythrocyte count.
 cancers

- Lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell.  

- Melanoma

- Prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men.  

Etc

Target More than 50 different targets. Examples:

- BCL BCL - The successor to Atlas Commercial Language.

["The Provisional BCL Manual", D. Hendry, U London 1966].
2-associated X protein

- cancer/testis antigen 1

- CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)

- cyclin-dependent kinase inhibitor 1A (p21, Cip1)

- EphA2

- interleukin 10

- major histocompatibility complex major histocompatibility complex
n.
Abbr. MHC A chromosomal segment that codes for cell-surface histocompatibility antigens and is the principal determinant of tissue type and transplant compatibility. Also called HLA complex.
, class I, B

- toll-like receptor 7

- transforming protein E7, human papilloma papilloma /pap·il·lo·ma/ (pap?il-o´mah) a benign tumor derived from epithelium.papillo´matous

fibroepithelial papilloma  a type containing extensive fibrous tissue.
 virus-16

- tumor-associated calcium signal transducer 1

Description Progress analysis and review of drug development.

A typical drug profile reports on:

- Drug Name & Synonyms

- Investigator(s)

- Indication(s)

- Developmental Stage(s)

- Mechanism(s)

- Target(s)

- Clinical Development

- Developmental History

- Scientific Data

- Patents

- In/Out-licensing

- Collaborations

- Analysts Comments

How May Drug Pipeline Update Be of Use?

Show investors/board/management that you are right on top of drug development progress in your therapeutic area.

Find competitors, collaborations partners, M&A candidates etc.

Jump start competitive drug intelligence operations

Excellent starting point for world wide benchmarking

Compare portfolio and therapy focus with your peers

Speed up pro-active in-/outlicensing strategy work

Fast and easy way of tracking drugs using search engines; just one click and you may search World Wide Web and PubMed for any drug with all its synonyms.

Drug Pipeline Update is delivered to you as a CD-ROM CD-ROM: see compact disc.
CD-ROM
 in full compact disc read-only memory

Type of computer storage medium that is read optically (e.g., by a laser).
 application

Drug Pipeline Update is fitted into a CD-ROM based application, for your intelligent usage:

Smart CD-ROM application, which makes it easy to use and navigate by

Multiple search and sort functions included

Drug data is linked to search engines like Google and PubMed

Direct links to web pages from inside the application

Found information is easily shared with others over email, file export or in print

System Requirements

AMD-Athlon/Pentium II PC

Windows 98/NT4/2000/ME/XP

8x-speed CD Rom drive

SVGA (Super VGA) A screen resolution of 800x600 pixels. Third-party vendors extended IBM's VGA display standard and were the first to use the term. SVGA has also referred to 1,024x768 resolutions. See PC display modes.  16 bit display. (32 bit recommended)

32 MB of available RAM (128 MB recommended)

Internet access (to test web-enabled presentations)

For more information visit http://www.researchandmarkets.com/reports/c35509
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 12, 2008
Words:532
Previous Article:The MathWorks Simplifies Development of Parallel Applications in MATLAB.
Next Article:BJ's Wholesale Club to Announce First Quarter Results on May 21, 2008.
Topics:



Related Articles
Galenica acquisition finalized.
GERON LICENSES MAXCYTE CELL LOADING TECHNOLOGY.
Taking a jab at cancer: combined with drugs, vaccines against tumors may finally be working.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles